Draft Labelling Rules For Prescription Drugs Unveiled - Mint

View Market Dashboard
  • Home
  • Markets
    • Market News
    • Stock Markets
    • IPO
    • US Markets
    • Mark to Market
    • Bonds
    • Commodities
    • Cryptocurrency
    • Market Data
    • Stock Pages
    • Index pages
    • Bullion
    • Gold
    • Silver
    • Fuel
    • Petrol
    • Diesel
  • News
    • India
    • World
    • WSJ
    • Economist
    • US News
    • Trends
  • Premium
    • e-paper
    • Global Partners
    • WSJ
    • Economist
    • Barron's
    • Mint Specials
    • Mint Explainers
    • Mark to Market
    • Long Story
    • Plain Facts
    • Snapview
    • Sections
    • Companies
    • Technology
    • Markets
    • Personal Finance
    • Mutual Funds
    • Insurance
    • Auto
    • Industry
    • Lounge
    • Opinion
  • Budget 2026
  • Latest News
  • Companies
    • Start-ups
    • Company Results
    • People
  • Money
    • Personal Finance
    • Insurance
    • Ask Mint Money
    • Mutual Funds
    • MyMint
  • T20 World Cup 2026
  • Technology
    • Gadgets
    • Tech Reviews
    • App News
    • 5G Tech
    • Foldable Smartphones
  • Mint Hindi
  • More
    • Election 2026
    • Sports
    • Cricket News
    • Science
    • Health
    • Entertainment
    • Tools
    • IFSC Code Finder
    • Income Tax Calculator
    • Gold Rate Today
    • Gold Rate in Delhi
    • Gold Rate Hyderabad
    • Silver Rate Today
    • Silver Rate in Delhi
    • Silver Rate in Bangalore
    • US
    • US Trending
    • Hollywood
    • Business
    • US Stock Market
    • Explore Mint
    • About us
    • Print subscription
    • Subscriber terms of use
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    • Mint code
    • Cookie Policy
    • Code of ethics
    • Sitemap
    • Contact Us
    • Hindustan Times
    • Live Hindustan
    • Healthshots
    • HT US News
    • HT Auto
    • HT Tech
    • Nifty 50
    • Auto News
    • Mint Money
Hello UserSign inSign OutMy Account
  • Subscribe
  • My Watchlist
  • Newsletters
  • My Vouchers
  • Notifications
  • My Reads
  • For You
View Less -View More +Data Insights
  • Market Dashboard
  • Bullion
    • Gold
    • Silver
  • Fuel
    • Petrol
    • Diesel
  • Commodities
    • Gold
    • GoldM
    • Aluminium
    • Menthaoil
    • Silver
    • SilverMIC
    • GoldPetal
    • Natural Gas
    • Copper
    • Zinc
    • SilverM
    • CrudeOil
    • GoldGinuea
    • Lead
  • Cryptocurrency
  • Smart Money
  • Gold Prices Today
    • Gold Price in Delhi
    • Gold Price in Mumbai
    • Gold Price in Chennai
    • Gold Price in Hyderabad
    • Gold Price in Kolkata
  • Silver Prices Today
    • Silver Price in Delhi
    • Silver Price in Mumbai
    • Silver Price in Chennai
    • Silver Price in Hyderabad
    • Silver Price in Kolkata
View Less -View More +Top Sections
  • Latest News Today
    • India News
    • World News
    • US News Today
  • Markets
    • Stock Markets
    • IPO News
    • US Stock Market Today
    • Mark To Market
    • Bonds
    • Commodity News
    • Cryptocurrency
  • Companies
    • IPO News
    • Start-ups
    • Company Results
    • Top Company Leader
  • Premium
  • Money News
    • Personal Finance
    • Q&A
    • Opinion
  • Economy
  • Technology News
    • Gadgets
    • Tech Reviews
    • App News
  • Personal Loan
    • personal loan emi calculator
    • Personal Loan Interest Rate
    • Personal Loan Eligibility
    • Business Loan
    • Instant Personal Loan
  • Brand Studio
    • Oracle CXO Leaders DialogueCXO Leaders Dialogue
    • Oracle CXO Leaders Dialogue Hyderabad
    • Oracle Seamless Cloud Migration
    • Oracle Scaling Ambitions ​
    • Oracle Mastering Multi cloud Strategy
    • Zoho The Long Game
    • Thoughtworks Digital Banking Platform Journey
    • Lentra The State of Credit
    • Mirae Asset MF Winning Over Volatility
    • PGIM India MF Amend, Adjust, Adapt
    • Goalteller Personal Financial Strategies
    • Oracle Unlock The Value of CX
    • Microsoft Future Tech Series
    • Zoho Navigating The Future Of Work
    • Databricks Generation AI Series
    • Microsoft Future Ready
    • Salesforce Tech4good Awards
    • Rolling with the Boss
    • Fairfox The Unstoppables
    • Focus
View Less -View More +Premium Offerings
  • e-paper
  • WSJ
  • Economist
  • Barron's
  • MyMint
  • Mint Premium
View Less -View More +Tools and Calculators
  • IFSC Code Finder
  • Income Tax Calculator
  • SIP Calculator
  • EMI Calculator
  • Home Loan EMI Calculator
  • Car Loan EMI
  • NPS Calculator
View Less -View More +MultiMedia Collections
  • Videos
  • Photos
  • Podcasts
View Less -View More +More From Mint
  • Mint Lounge
  • Mint Hindi
  • Livehindustan
  • Hindustan Times
View Less -Explore Mint
  • About Us
  • Print Subscription
  • Mint Authors
  • Terms of Use
  • Disclaimer
  • Mint Code
  • Code of ethics
  • Cookie Policy
  • Privacy Policy
  • Privacy and cookie settings
  • Subscriber - Terms of Use
  • SITEMAP
  • Contact Us
  • Mint Apps
View Less -View More +Copyright © HT Digital Streams Limited All Rights Reserved.Draft labelling rules for prescription drugs unveiled

Antibiotics, other prescription drugs must come in packages with warnings printed inside a red rectangular box, the health ministry suggests in its labelling rules

Teena ThackerUpdated14 Nov 2017, 01:18 AM IST
Prescription drugs are those that require a medical prescription to be dispensed, unlike over-the-counter drugs. Photo: Mint
Prescription drugs are those that require a medical prescription to be dispensed, unlike over-the-counter drugs. Photo: Mint

New Delhi: Antibiotics and other prescription drugs must come in packages with warnings printed inside a red rectangular box, the health ministry has suggested in its latest labelling rules aimed at checking antimicrobial drug resistance in India.

Prescription drugs are those that require a medical prescription to be dispensed, unlike over-the-counter drugs.

The ministry had earlier proposed a conspicuous red vertical band running throughout the body of the package with the words “schedule drug” printed on it. However, the regulatory body on drugs and devices—the Central Drugs Standard Control Organisation (CDSCO)—put out a draft notification on its website on Monday with new labelling rules seeking comments and suggestions from stakeholders.

According to the draft, the new rules will apply to antibiotics, anti-diabetic drugs, corticosteroids, hormones, anti cancer drugs, narcotic analgesics, hypnotics, sedatives, painkillers, sedatives, tranquillizers, antiepileptics, antidepressants, anticoagulants and all other drugs that fall under Schedules G, H, H1 or X. Each schedule represents a different level of restriction.

The move reflects concern over widespread abuse of antibiotics that has contributed to the emergence of multi-drug-resistant bacteria in the country.

For Schedule H1 drugs, which cover key antibiotics and already carry the vertical red band, manufacturers will have to carry a message, “It is dangerous to take this preparation except in accordance with the medical advice. Not to be sold by retail without the prescription of a registered medical practitioner.”

Chinu Srinivasan from All India Drugs Action Network said, “This will probably be helpful to the drug inspectors. It will not make any difference for the run of the mill consumer. It will not end sale of over-the-counter drugs”.

Schedule G drugs are mainly hormone-based preparations and need to be taken under a doctor’s supervision.

As per the new draft rule, if drug substance in Schedule G is contained, the label should carry a caution “It is dangerous to take this preparation except under medical supervision” in legible black coloured font size in red rectangular box.

Medicines under the other schedules are not supposed to be sold over the counter and can be sold only through a prescription. Drugs under Schedule H can be sold only based on the prescription of a registered medical practitioner and only the amount specified in the prescription should be sold.

As per the new draft rules, the drugs under Schedule H be labelled with “symbol Rx and conspicuously displayed on the left top corner of the label and shall also be labelled with the following words in legible black coloured font size in completely red rectangular: ‘Not to be sold by the retail without the prescription of a registered medical practitioner’.”

The draft rule says that if a medicine contains a drug substance specified in Schedule H and comes within the purview of the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985) it should be labelled with symbol NRx which shall be in red and conspicuously displayed on the left top corner of the label and shall also be labelled with the same words as prescribed for Schedule H drugs in legible black coloured font size and in red rectangular box.

For the Schedule X drugs, retailers have to maintain the copy of prescription for two years and the drugs should be labelled with the symbol ‘XRx’ and conspicuously displayed on the left top corner of the label. Schedule X includes narcotic and psychotropic substances-based drugs, reads the draft rules.

Catch all the Industry News, Banking News and Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Business NewsIndustryManufacturingDraft labelling rules for prescription drugs unveiledMore